Pfizer, U.K. experts seek approval for stem cell clinical trial

10/9/2011 | Wall Street Journal, The

Pfizer and scientists at the University College London's Institute of Ophthalmology have asked U.K. regulators to allow them to start a clinical trial of retinal cells, derived from human embryonic stem cells, in patients with age-related macular degeneration. They hope to conduct the U.K. study in 2012.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ